E uiga i le kanesa / togafitiga / vailaʻau / paʻu
Fualaʻau Faʻamaonia mo le Kanesa o le Paʻu
Lenei itulau lisi lisi o kanesa fualaʻau faʻamaonia e le Taumafa ma Vailaau Faʻataʻitaʻiga (FDA) mo paʻu kanesa, aofia ai vailaʻau mo basal cell carcinoma, melanoma, ma merkel sela kanesa o O le lisi aofia ai igoa lautele ma igoa igoa. O igoa o fualaʻau e fesoʻotaʻi atu i faʻamaumauga a le NCI o le Kanesa o Vailaʻau. Atonu e iai vailaʻau e faʻaaogaina ile kanesa ole paʻu e leʻo lisiina ii.
I LENEI ITULAU
- Fualaʻau Faʻamaonia mo Basal Cell Carcinoma
- Fualaʻau Faʻamaonia mo Cutaneous Squamous Cell Carcinoma
- Faʻamaonia Vailaau mo Melanoma
- Fualaʻau Faʻamaonia mo Merkel Cell Carcinoma
Fualaʻau Faʻamaonia mo Basal Cell Carcinoma
Aldara (Imiquimod)
Efudex (Fluorouracil - Autu)
Erivedge (Vismodegib)
5-FU (Fluorouracil - Autu)
Fluorouracil - Autu
Imiquimod
Odomzo (Sonidegib)
Sonidegib
Vismodegib
Fualaʻau Faʻamaonia mo Cutaneous Squamous Cell Carcinoma
Cemiplimab-rwlc
Libtayo (Cemiplimab-rwlc)
Faʻamaonia Vailaau mo Melanoma
Aldesleukin
Cobimetinib
Cotellic (Cobimetinib)
Dabrafenib
Dacarbazine
DTIC-Dome (Dacarbazine)
IL-2 (Aldesleukin)
Imlygic (Talimogene Laherparepvec)
Interleukin-2 (Aldesleukin)
Intron A (Recombinant Interferon Alfa-2b)
Ipilimumab
Keytruda (Pembrolizumab)
Mekinist (Trametinib)
Nivolumab
Opdivo (Nivolumab)
Peginterferon Alfa-2b
Pembrolizumab
Proleukin (Aldesleukin)
Recombinant Interferon Alfa-2b
Sylatron (Peginterferon Alfa-2b)
Tafinlar (Dabrafenib)
Talimogene Laherparepvec
Trametinib
Vemurafenib
Yervoy (Ipilimumab)
Zelboraf (Vemurafenib)
Fualaʻau Faʻamaonia mo Merkel Cell Carcinoma
Avelumab
Bavencio (Avelumab)
Keytruda (Pembrolizumab)
Pembrolizumab
